|
Market Closed -
OTC Markets
22:10:25 22/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.470 USD | +0.31% |
|
-0.46% | +5.19% |
EPS & Dividend: Interpace Biosciences, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -36.61 | -18.09 | -25.91 | 0.8948 | 1.972 | 4.426 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 15.700 | 37.350 | 5.200 | 5.400 | 13.488 | 6.151 |
| Nbr of stocks (in thousands) | 808 | 835 | 853 | 869 | 880 | 886 |
| Announcement Date | 01/04/21 | 31/03/22 | 27/03/23 | 01/04/24 | 31/03/25 | 30/03/26 |
1USD in Million2USD
Estimates
Past dividends: Interpace Biosciences, Inc.
| 27/08/2026 | Significant Split/Dividend | 08:00 |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -286.96x | 29.03x | 19x | |
| 0.94% | 0.95% | 22.36x | 2.81x | 2.06x | |
| 5.61% | 5.6% | 15.6x | 1.08x | 1.24x | |
| - | - | 1056.14x | - | - | |
| 0.97% | 1.05% | 51.61x | 11.18x | 9.52x | |
| - | - | -27.06x | - | - | |
| -.--% | -.--% | -63.76x | - | - | |
| 4.84% | 5.95% | 15.99x | 2.26x | 1.67x | |
| 1.37% | 2.05% | 32.84x | 1.9x | 1.72x | |
| Average | 1.96% | 2.23% | 90.75x | 8.04x | 5.87x | |
| Weighted average by Cap. | 0.8% | 0.84% | -87.03x | 18.34x | 12.19x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
